Gillette Children's Specialty Healthcare is a non-profit hospital located in St. Paul, Minnesota, USA.

There are 60 beds in Gillette Children's Specialty Healthcare.

During the past decade, Gillette Children's Specialty Healthcare conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 10 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 8 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gillette Children's Specialty Healthcare" #1 sponsor was "Gillette Children's Specialty Healthcare" with 14 trials, followed by "ACADIA Pharmaceuticals Inc." with 3 trials sponsored, "Allergan" with 2 trials sponsored, "Neuren Pharmaceuticals Limited" with 2 trials sponsored and "Santhera Pharmaceuticals" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gillette Children's Specialty Healthcare" #1 collaborator was "Gillette Children's Specialty Healthcare" with 6 trials as a collaborator, "University of Minnesota" with 4 trials as a collaborator, "Baylor College of Medicine" with 3 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 3 trials as a collaborator. Other collaborators include 76 different institutions and companies that were collaborators in the rest 76 trials.

According to Clinical.Site data, the most researched conditions in "Gillette Children's Specialty Healthcare" are "Cerebral Palsy" (12 trials), "Rett Syndrome" (10 trials), "Spinal Muscular Atrophy" (4 trials), "Anti-myostatin" (2 trials) and "Atrophy" (2 trials). Many other conditions were trialed in "Gillette Children's Specialty Healthcare" in a lesser frequency.

Most popular intervention types in "Gillette Children's Specialty Healthcare" are "Drug" (19 trials), "Other" (11 trials), "Device" (9 trials), "Procedure" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Assisted Standing Treatment Program" (3 trials), "Apitegromab" (2 trials), "NNZ-2566" (2 trials) and "Surveys" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gillette Children's Specialty Healthcare" are 38 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 13 active trials in "Gillette Children's Specialty Healthcare". 2 are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 23 completed trials in Gillette Children's Specialty Healthcare, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Gillette Children's Specialty Healthcare, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 13 trials that are defined as “Not Applicable".

Gillette Children's Specialty Healthcare has several departments that took part in Clinical trials: "Gillette Children's Speciality Healthcare" - 3 trials